Accendra Health, Inc. (ACH) Q2 FY26 Earnings Call

Execution delays and payer collections cut 2026 expectations, while late-year contracts, cost actions, and deleveraging support the 2027 setup.

Q2 FY26 results, source: company transcript and SEC filings
QuarterQ2 FY26
Call date2026-08-10
Length46 minutes
EPS$-0.19
EPS consensus$-0.13
Revenue$613.2M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q1 FY26

All ACH earnings ยท Back to ACH overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.